Inventor · disambiguated record
Herve Broly
Also filed as: BROLY HERVE · BROLY HERVÉ
16 granted patents·2 pending applications·81 citations·filing 1992–2019
90Inventor score
Files withARES TRADING SA9FRESENIUS KABI DEUTSCHLAND GMBH3BROLY HERVE2AETSRN1CENTRE REGIONAL DE TRANSFUSION1
Top patents by PatentIndex Score
18 records- 0186US10526631B1Method of reducing serine for asparagine misincorporationARES TRADING SA·Filed 2017·Granted Jan 7, 2020·4 cites·22 claims
- 0280US8956611B2Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune diseasePONCE JR RAFAEL A·Filed 2008·Granted Feb 17, 2015·9 cites·10 claims
- 0379US10519479B1Methods for modifying glycosylation using manganeseARES TRADING SA·Filed 2017·Granted Dec 31, 2019·2 cites·15 claims
- 0478US11186858B1Methods for increasing biosimilarityFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Granted Nov 30, 2021·1 cites·7 claims
- 0570US8808696B2Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion moleculesBROLY HERVE·Filed 2006·Granted Aug 19, 2014·2 cites·16 claims
- 0670US5851524AHuman monoclonal anti-rhesus (D) antibodies and cell lines producing sameAETSRN·Filed 1997·Granted Dec 22, 1998·25 cites·5 claims
- 0768US5474770ABiological support for cell cultures constituted by plasma proteins coagulated by thrombin, its use in the preparation of keratocyte cultures, their recovery and their transport for therapeutic purposesCENTRE REGIONAL DE TRANSFUSION·Filed 1992·Granted Dec 12, 1995·35 cites·16 claims
- 0867US8784812B2Methods for treating autoimmune diseases using a TACI-Ig fusion moleculeBROLY HERVE·Filed 2007·Granted Jul 22, 2014·2 cites·17 claims
- 0966US7842292B2Methods for treating B-cell malignancies using a TACI-Ig fusion moleculeARES TRADING SA·Filed 2006·Granted Nov 30, 2010·1 cites·19 claims
- 1050US11566062B2Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycinARES TRADING SA·Filed 2018·Granted Jan 31, 2023·0 cites·10 claims
- 1148US2021147532A1Method for controlling the afucosylation level of a glycoprotein compositionARES TRADING SA·Filed 2019·Application pending·0 cites
- 1247US10745663B2Methods for modulating production profiles of recombinant proteinsARES TRADING SA·Filed 2016·Granted Aug 18, 2020·0 cites·6 claims
- 1346US11118208B2Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactoseARES TRADING SA·Filed 2017·Granted Sep 14, 2021·0 cites·6 claims
- 1446US10767160B2Methods for modulating production profiles of recombinant proteinsARES TRADING SA·Filed 2016·Granted Sep 8, 2020·0 cites·3 claims
- 1543US11254964B1Cell culture methods for increased cell viabilityFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2017·Granted Feb 22, 2022·0 cites·13 claims
- 1642US10138467B2Medium for high performance mammalian fed-batch culturesARES TRADING SA·Filed 2014·Granted Nov 27, 2018·0 cites·9 claims
- 1736US11919924B1Methods of purifying and producing an adalimumab antibodyFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
- 1836US2016051671A1COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASEZYMOGENETICS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →